Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16

2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36

3 Segmentation of Asia Pacific Market by Product 40
3.1 Market Overview by Product 40
3.2 Pre-filled Syringes 42
3.3 Multidose Eyedroppers 43
3.4 Squeeze Dispensers 44
3.5 Mist Sprayers 45
3.6 Contact Lenses 46
3.7 Ocular Inserts 47
3.8 Intraocular Implants 48
3.9 Punctal Plugs 49
3.10 Other Products 50

4 Segmentation of Asia Pacific Market by Dosage Form 51
4.1 Market Overview by Dosage Form 51
4.2 Solutions 53
4.3 Gels 54
4.4 Ointments 55
4.5 Suspensions 56
4.6 Emulsions 57
4.7 Liposomes & Nanoparticles 58

5 Segmentation of Asia Pacific Market by Disease 59
5.1 Market Overview by Disease 59
5.2 Glaucoma 61
5.3 Diabetic Retinopathy 62
5.4 Cataract 63
5.5 Dry Eye Syndrome 64
5.6 Macular Degeneration 65
5.7 Diabetic Macular Edema 66
5.8 Refractive Issues 67
5.9 Other Diseases 68

6 Segmentation of Asia Pacific Market by Setting 69
6.1 Market Overview by Setting 69
6.2 Hospitals 71
6.3 Clinics 72
6.4 Homecare Settings 73
6.5 Ambulatory Surgical Centers (ASCs) 74
6.6 Other Settings 75

7 Asia-Pacific Market 2021-2031 by Country 76
7.1 Overview of Asia-Pacific Market 76
7.2 Japan 79
7.3 China 83
7.4 Australia 86
7.5 India 89
7.6 South Korea 92
7.7 Rest of APAC Region 95

8 Competitive Landscape 97
8.1 Overview of Key Vendors 97
8.2 New Product Launch, Partnership, Investment, and M&A 100
8.3 Company Profiles 101
Aero Pump GmbH 101
Allergan plc. 103
AptarGroup, Inc. 104
Becton, Dickinson and Company 105
Biocorp 106
Clearside Biomedical, Inc. 107
EyePoint Pharmaceuticals, Inc. 108
Gaplast GmbH 109
Gerresheimer AG 110
Jotteq Inc. 111
Kedalion Therapeutics, Inc. 112
Mati Therapeutics, Inc. 113
Nemera 114
Nipro Corporation 115
Ocular Therapeutix, Inc. 116
Ocumedic, Inc. 117
Owen Mumford 118
Re-Vana Therapeutics 119
Silgan Holdings Inc. 120
Terumo Corporation 121
Valeant Pharmaceuticals International Inc. (Bausch Health Company) 122
West Pharmaceutical Services, Inc. 123
RELATED REPORTS 124



List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Industry Value Chain Analysis 19
Figure 5. Asia Pacific Ophthalmic Drug Delivery System Market, 2021-2031, $ mn 20
Figure 6. Impact of COVID-19 on Business 23
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Ophthalmic Drug Delivery System Market 25
Figure 8. Number of Population Affected by Vision Impairment, All Ages by Sex, 1990–2050F 28
Figure 9. Primary Restraints and Impact Factors of Asia Pacific Ophthalmic Drug Delivery System Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of Asia Pacific Ophthalmic Drug Delivery System Market 36
Figure 12. Breakdown of Asia Pacific Ophthalmic Drug Delivery System Market by Product, 2021-2031, % of Revenue 41
Figure 13. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 41
Figure 14. Asia Pacific Ophthalmic Drug Delivery System Market by Product: Pre-filled Syringes, 2021-2031, $ mn 42
Figure 15. Asia Pacific Ophthalmic Drug Delivery System Market by Product: Multidose Eyedroppers, 2021-2031, $ mn 43
Figure 16. Asia Pacific Ophthalmic Drug Delivery System Market by Product: Squeeze Dispensers, 2021-2031, $ mn 44
Figure 17. Asia Pacific Ophthalmic Drug Delivery System Market by Product: Mist Sprayers, 2021-2031, $ mn 45
Figure 18. Asia Pacific Ophthalmic Drug Delivery System Market by Product: Contact Lenses, 2021-2031, $ mn 46
Figure 19. Asia Pacific Ophthalmic Drug Delivery System Market by Product: Ocular Inserts, 2021-2031, $ mn 47
Figure 20. Asia Pacific Ophthalmic Drug Delivery System Market by Product: Intraocular Implants, 2021-2031, $ mn 48
Figure 21. Asia Pacific Ophthalmic Drug Delivery System Market by Product: Punctal Plugs, 2021-2031, $ mn 49
Figure 22. Asia Pacific Ophthalmic Drug Delivery System Market by Product: Other Products, 2021-2031, $ mn 50
Figure 23. Breakdown of Asia Pacific Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, % of Sales Revenue 52
Figure 24. Asia Pacific Addressable Market Cap in 2022-2031 by Dosage Form, Value ($ mn) and Share (%) 52
Figure 25. Asia Pacific Ophthalmic Drug Delivery System Market by Dosage Form: Solutions, 2021-2031, $ mn 53
Figure 26. Asia Pacific Ophthalmic Drug Delivery System Market by Dosage Form: Gels, 2021-2031, $ mn 54
Figure 27. Asia Pacific Ophthalmic Drug Delivery System Market by Dosage Form: Ointments, 2021-2031, $ mn 55
Figure 28. Asia Pacific Ophthalmic Drug Delivery System Market by Dosage Form: Suspensions, 2021-2031, $ mn 56
Figure 29. Asia Pacific Ophthalmic Drug Delivery System Market by Dosage Form: Emulsions, 2021-2031, $ mn 57
Figure 30. Asia Pacific Ophthalmic Drug Delivery System Market by Dosage Form: Liposomes & Nanoparticles, 2021-2031, $ mn 58
Figure 31. Breakdown of Asia Pacific Ophthalmic Drug Delivery System Market by Disease, 2021-2031, % of Sales Revenue 60
Figure 32. Asia Pacific Addressable Market Cap in 2022-2031 by Disease, Value ($ mn) and Share (%) 60
Figure 33. Asia Pacific Ophthalmic Drug Delivery System Market by Disease: Glaucoma, 2021-2031, $ mn 61
Figure 34. Asia Pacific Ophthalmic Drug Delivery System Market by Disease: Diabetic Retinopathy, 2021-2031, $ mn 62
Figure 35. Asia Pacific Ophthalmic Drug Delivery System Market by Disease: Cataract, 2021-2031, $ mn 63
Figure 36. Asia Pacific Ophthalmic Drug Delivery System Market by Disease: Dry Eye Syndrome, 2021-2031, $ mn 64
Figure 37. Asia Pacific Ophthalmic Drug Delivery System Market by Disease: Macular Degeneration, 2021-2031, $ mn 65
Figure 38. Asia Pacific Ophthalmic Drug Delivery System Market by Disease: Diabetic Macular Edema, 2021-2031, $ mn 66
Figure 39. Asia Pacific Ophthalmic Drug Delivery System Market by Disease: Refractive Issues, 2021-2031, $ mn 67
Figure 40. Asia Pacific Ophthalmic Drug Delivery System Market by Disease: Other Diseases, 2021-2031, $ mn 68
Figure 41. Breakdown of Asia Pacific Ophthalmic Drug Delivery System Market by Setting, 2021-2031, % of Revenue 70
Figure 42. Asia Pacific Addressable Market Cap in 2022-2031 by Setting, Value ($ mn) and Share (%) 70
Figure 43. Asia Pacific Ophthalmic Drug Delivery System Market by Setting: Hospitals, 2021-2031, $ mn 71
Figure 44. Asia Pacific Ophthalmic Drug Delivery System Market by Setting: Clinics, 2021-2031, $ mn 72
Figure 45. Asia Pacific Ophthalmic Drug Delivery System Market by Setting: Homecare Settings, 2021-2031, $ mn 73
Figure 46. Asia Pacific Ophthalmic Drug Delivery System Market by Setting: Ambulatory Surgical Centers (ASCs), 2021-2031, $ mn 74
Figure 47. Asia Pacific Ophthalmic Drug Delivery System Market by Setting: Other Settings, 2021-2031, $ mn 75
Figure 48. Breakdown of APAC Ophthalmic Drug Delivery System Market by Country, 2021 and 2031, % of Revenue 77
Figure 49. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 78
Figure 50. Ophthalmic Drug Delivery System Market in Japan, 2021-2031, $ mn 80
Figure 51. Ophthalmic Drug Delivery System Market in China, 2021-2031, $ mn 83
Figure 52. Ophthalmic Drug Delivery System Market in Australia, 2021-2031, $ mn 86
Figure 53. Ophthalmic Drug Delivery System Market in India, 2021-2031, $ mn 89
Figure 54. Ophthalmic Drug Delivery System Market in South Korea, 2021-2031, $ mn 92
Figure 55. Ophthalmic Drug Delivery System Market in Rest of APAC, 2021-2031, $ mn 95
Figure 56. Growth Stage of Asia Pacific Ophthalmic Drug Delivery System Industry over the Forecast Period 97

List of Tables

List of Tables:

Table 1. Snapshot of Asia Pacific Ophthalmic Drug Delivery System Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 22
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Ophthalmic Drug Delivery System Market 32
Table 4. Asia Pacific Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 40
Table 5. Asia Pacific Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 51
Table 6. Asia Pacific Ophthalmic Drug Delivery System Market by Disease, 2021-2031, $ mn 59
Table 7. Asia Pacific Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 69
Table 8. APAC Ophthalmic Drug Delivery System Market by Country, 2021-2031, $ mn 77
Table 9. Japan Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 81
Table 10. Japan Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 81
Table 11. Japan Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 82
Table 12. China Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 84
Table 13. China Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 84
Table 14. China Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 85
Table 15. Australia Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 87
Table 16. Australia Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 87
Table 17. Australia Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 88
Table 18. India Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 90
Table 19. India Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 90
Table 20. India Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 91
Table 21. South Korea Ophthalmic Drug Delivery System Market by Product, 2021-2031, $ mn 93
Table 22. South Korea Ophthalmic Drug Delivery System Market by Dosage Form, 2021-2031, $ mn 93
Table 23. South Korea Ophthalmic Drug Delivery System Market by Setting, 2021-2031, $ mn 94
Table 24. Ophthalmic Drug Delivery System Market in Rest of APAC by Country/Region, 2021-2031, $ mn 96
Table 25. Aero Pump GmbH: Company Snapshot 101
Table 26. Aero Pump GmbH: Business Segmentation 102
Table 27. Aero Pump GmbH: Product Portfolio 102